ConcertAI's TeraRecon Partners with CoLumbo to Expand its Eureka Clinical AI Platform

Friday, July 21, 2023

TeraRecon, a leading company in advanced visualization and AI and a part of ConcertAI, has announced a strategic partnership with CoLumbo to integrate state-of-the-art machine learning technology into its Eureka Clinical AI platform. This integration will enable clinicians to utilize advanced tools for reading and analyzing lumbar spine MR scans.

The CoLumbo solution employs deep learning algorithms to provide accurate and efficient information on suspected pathologies and abnormality detection in lumbar spine MR scans, including conditions like herniated discs and spinal stenosis. By offering a non-invasive and safe method for analyzing spinal conditions, CoLumbo facilitates earlier intervention and improved patient outcomes.

One of the notable advantages of CoLumbo is its ability to reduce reading and reporting time for radiologists by up to 48%, enabling them to examine more patients while enhancing the accuracy of image interpretation. Clinical trials have shown that CoLumbo can reduce errors of omission by up to 15%.

The collaboration between TeraRecon and CoLumbo represents a significant advancement in spinal diagnostics for healthcare providers across the United States, Europe, and Australia. With TeraRecon's extensive global installed base of approximately 1,900 health sites, CoLumbo's unique analysis capabilities will now be widely accessible.

Nikolay Todorov, CCO and Co-Founder of CoLumbo, expressed enthusiasm about the partnership, stating, "We are thrilled to be a part of the TeraRecon AI partner ecosystem and to offer our solution both on the Eureka Clinical AI platform and to all healthcare providers needing these services in the streamlined and best-in-breed ecosystem that TeraRecon offers."

Dan McSweeney, President of TeraRecon, also shared his excitement, saying, "I am thrilled to announce our groundbreaking partnership with CoLumbo, uniting our strengths and expertise in healthcare imaging with the power of the Eureka AI Platform. This collaboration marks a significant milestone in our mission to deliver cutting-edge solutions, and we are excited to embark on this transformative journey, unlocking new frontiers in patient care and outcomes."

Eureka Clinical AI, from ConcertAI's TeraRecon, is a leading AI SaaS imaging interpretation and clinical decision augmentation solution. Notably, it is an open platform that accommodates third-party AI algorithms, allowing seamless PACS integrations and consolidated management of all AI interpretation solutions. The platform empowers multi-specialty care teams to access results and receive mobile alerts to confirm AI findings, facilitating optimal and timely patient interventions, management, and coordinated care delivery.

Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare Innovation & Transformation SummitHealthcare CNO SummitHealthcare CMO SummitThe Healthcare Patient Experience & Engagement Summit 2024